• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 7300TFX27
Device Problems Perivalvular Leak (1457); Incomplete Coaptation (2507); Appropriate Term/Code Not Available (3191)
Patient Problems Failure of Implant (1924); Mitral Regurgitation (1964); Mitral Valve Stenosis (1965)
Event Date 06/10/2020
Event Type  Injury  
Manufacturer Narrative
Stenosis and/or regurgitation, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explants and encompasses multiple failure modes, including calcification, non-calcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, nonstructural dysfunction (nsvd) may also play a role in the development of valvular stenosis and/or regurgitation.The root cause of this event cannot be conclusively determined with the available information.However, the stenosis and regurgitation in this case were most likely impacted by the progression of the patient¿s underlying valvular disease pathology with or without structural valve deterioration and/or nonstructural dysfunction.The subject device is not available for evaluation, as it remains implanted in the patient.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was reported that a patient with a 27mm 7300tfx (cp-2020-10235-1) pericardial mitral valve underwent a valve-in-valve procedure after an implant duration of seven (7) years, 10 months due to severe symptomatic mitral stenosis regurgitation.The tmvr procedure was performed with a 29mm 9600tfx transcatheter valve.A small anteriorly directed paravalvular leak was noted.The patient was taken to the icu in stable and awake condition.There were no complications and the procedure was tolerated well.The patient was discharged home on pod #2 in stable condition.Per received medical records it was learned that the patient's 21mm 3300tfx (cp-2020-10235-2) pericardial aortic valve had exhibited severe dysfunction and had undergone valve-in-valve intervention after an implant duration of approximately seven (7) years, eight (8) months.The tavr procedure was noted to have been uneventful.Model number and size of the transcatheter valve implanted in the aortic position is unknown.The patient was noted to have been doing well in the two (2) months prior to the tmvr procedure.
 
Manufacturer Narrative
Updated: h6.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key10226256
MDR Text Key199991627
Report Number2015691-2020-12407
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
PMA/PMN Number
P860057/S068
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 07/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/21/2016
Device Model Number7300TFX27
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age81 YR
-
-